Impax To Ramp Up Sales Team, Diversify From Generics After Positive IPX066 Data
This article was originally published in The Pink Sheet Daily
Executive Summary
Impax plans to file an NDA for IPX066 for Parkinson's disease in the fourth quarter; the drug is partnered with GlaxoSmithKline outside the U.S.